or Try an Advanced Search...

    Technical Analysis for BNR - Burning Rock Biotech Limited

    Grade Last Price % Change Price Change
    F 6.28 -2.59% -0.17
    BNR closed down 2.59 percent on Monday, July 1, 2024, on 46 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical BNR trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Gapped Down Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish -2.59%
    Gilligan's Island Buy Setup Bullish Swing Setup -2.59%
    Narrow Range Bar Range Contraction -2.59%
    Down 3 Days in a Row Weakness -2.59%
    Older End-of-Day Signals for BNR ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 6 hours ago
    60 Minute Opening Range Breakout about 6 hours ago
    Gapped Down (Full) about 10 hours ago
    Down 5% about 10 hours ago
    Down 3% about 10 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    BNR Chart by TradingView
    Basic chart:

    Profile

    Burning Rock Biotech develops cancer diagnostic treatment based on deoxyribonucleic acid (DNA). The company provides tumor gene detection, liquid biopsy, hereditary tumor gene detection, tumor benign, and precision clinical trail for lung cancer, breast cancer, colorectal cancer, prostatic cancer, thyroid cancer, and hereditary tumors. Burning Rock Biotech was founded in January 2014, and is based in Guangzhou, China with additional locations in Beijing and Shanghai, China.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Medicine Cancer Clinical Medicine Acid Oncology Tumor Breast Cancer Prostate Cancer Colorectal Cancer Lung Cancer Thyroid Biopsy Thyroid Cancer Hereditary Cancers

    Is BNR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 3 Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
    May 30 Burning Rock Biotech joins hands with Bayer to expand precision cancer therapies portfolio
    May 30 Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
    May 30 Q1 2024 Burning Rock Biotech Ltd Earnings Call
    May 29 Burning Rock Biotech Limited (BNR) Q1 2024 Earnings Call Transcript
    May 29 Burning Rock Biotech Limited 2024 Q1 - Results - Earnings Call Presentation
    May 29 Burning Rock Biotech GAAP EPS of -$0.16, revenue of $17.4M
    May 29 Burning Rock Reports First Quarter 2024 Financial Results
    May 23 Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024
    May 14 Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
    See more BNR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 24.1
    52 Week Low 5.722
    Average Volume 5,951
    200-Day Moving Average 8.48
    50-Day Moving Average 7.62
    20-Day Moving Average 7.15
    10-Day Moving Average 6.73
    Average True Range 0.31
    RSI (14) 21.88
    ADX 34.17
    +DI 11.22
    -DI 43.53
    Chandelier Exit (Long, 3 ATRs) 6.91
    Chandelier Exit (Short, 3 ATRs) 7.02
    Upper Bollinger Bands 8.16
    Lower Bollinger Band 6.14
    Percent B (%b) 0.07
    BandWidth 28.22
    MACD Line -0.34
    MACD Signal Line -0.25
    MACD Histogram -0.0981
    Fundamentals Value
    Market Cap 644.8 Million
    Num Shares 103 Million
    EPS -0.97
    Price-to-Earnings (P/E) Ratio -6.47
    Price-to-Sales 0.15
    Price-to-Book 0.73
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 6.73
    Resistance 3 (R3) 6.72 6.56 6.65
    Resistance 2 (R2) 6.56 6.45 6.56 6.63
    Resistance 1 (R1) 6.42 6.37 6.49 6.43 6.60
    Pivot Point 6.26 6.26 6.30 6.27 6.26
    Support 1 (S1) 6.12 6.15 6.19 6.13 5.96
    Support 2 (S2) 5.96 6.07 5.97 5.93
    Support 3 (S3) 5.82 5.96 5.91
    Support 4 (S4) 5.83